JP2017520528A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2017520528A5 JP2017520528A5 JP2016568605A JP2016568605A JP2017520528A5 JP 2017520528 A5 JP2017520528 A5 JP 2017520528A5 JP 2016568605 A JP2016568605 A JP 2016568605A JP 2016568605 A JP2016568605 A JP 2016568605A JP 2017520528 A5 JP2017520528 A5 JP 2017520528A5
- Authority
- JP
- Japan
- Prior art keywords
- unsubstituted
- alkyl
- substituted
- substituent
- halogen
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201462001188P | 2014-05-21 | 2014-05-21 | |
| US62/001,188 | 2014-05-21 | ||
| PCT/US2015/032069 WO2015179707A1 (en) | 2014-05-21 | 2015-05-21 | Imidazole derivatives as formyl peptide receptor modulators |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2017520528A JP2017520528A (ja) | 2017-07-27 |
| JP2017520528A5 true JP2017520528A5 (enExample) | 2018-07-05 |
| JP6660889B2 JP6660889B2 (ja) | 2020-03-11 |
Family
ID=53276329
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016568605A Expired - Fee Related JP6660889B2 (ja) | 2014-05-21 | 2015-05-21 | ホルミルペプチド受容体調節物質としてのイミダゾール誘導体 |
Country Status (12)
| Country | Link |
|---|---|
| US (2) | US10301269B2 (enExample) |
| EP (1) | EP3145916B1 (enExample) |
| JP (1) | JP6660889B2 (enExample) |
| KR (1) | KR20170005121A (enExample) |
| CN (1) | CN106458921B (enExample) |
| AU (2) | AU2015264021B2 (enExample) |
| BR (1) | BR112016027133A8 (enExample) |
| CA (1) | CA2948876A1 (enExample) |
| DK (1) | DK3145916T3 (enExample) |
| ES (1) | ES2788700T3 (enExample) |
| RU (1) | RU2748652C2 (enExample) |
| WO (1) | WO2015179707A1 (enExample) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US12478503B2 (en) | 2009-05-18 | 2025-11-25 | Glaukos Corporation | Implants with controlled drug delivery features and methods of using same |
| US10206813B2 (en) | 2009-05-18 | 2019-02-19 | Dose Medical Corporation | Implants with controlled drug delivery features and methods of using same |
| AU2012329098B2 (en) | 2011-10-26 | 2017-08-03 | Allergan, Inc. | Amide derivatives of N-urea substituted amino acids as formyl peptide receptor like-1 (FPRL-1) receptor modulators |
| JP6196328B2 (ja) * | 2013-03-06 | 2017-09-13 | アラーガン、インコーポレイテッドＡｌｌｅｒｇａｎ，Ｉｎｃｏｒｐｏｒａｔｅｄ | 皮膚疾患を治療するためのホルミルペプチド受容体２アゴニストの使用 |
| JP6496728B2 (ja) | 2013-11-21 | 2019-04-03 | アラーガン、インコーポレイテッドＡｌｌｅｒｇａｎ，Ｉｎｃｏｒｐｏｒａｔｅｄ | ホルミルペプチド受容体の調節因子としてのカルバミン酸フェニル誘導体 |
| ES2788700T3 (es) | 2014-05-21 | 2020-10-22 | Allergan Inc | Derivados de imidazol como moduladores del receptor de péptido formilado |
| AU2017249047B2 (en) * | 2016-04-12 | 2021-08-05 | Allergan, Inc. | Phenyl urea derivatives as N-formyl peptide receptor modulators |
Family Cites Families (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2533210A1 (fr) | 1982-09-17 | 1984-03-23 | Lyon I Universite Claude | Edulcorants de synthese |
| KR20060130064A (ko) | 2003-11-07 | 2006-12-18 | 아카디아 파마슈티칼스 인코포레이티드 | 통증 및 염증 치료에 효과적인 화합물을 동정하기 위한도구로서의 리폭신 수용체, ｆｐｒｌ1의 용도 |
| PT1723128E (pt) | 2004-01-06 | 2013-02-27 | Novo Nordisk As | Heteroaril-ureias e o seu uso como activadores da glicoquinase |
| WO2007086584A1 (ja) * | 2006-01-30 | 2007-08-02 | Meiji Seika Kaisha, Ltd. | 新規ＦａｂＫおよびＦａｂＩ／Ｋ阻害剤 |
| AU2007287428B2 (en) * | 2006-08-24 | 2011-08-11 | Astrazeneca Ab | Morpholino pyrimidine derivatives useful in the treatment of proliferative disorders |
| WO2009000748A1 (en) | 2007-06-27 | 2008-12-31 | Solvay Fluor Gmbh | Preparation of compounds with a perfluoroalkylsulfonyl group |
| BRPI0814818A2 (pt) * | 2007-07-09 | 2019-09-10 | Astrazeneca Ab | composto, uso de um composto, métodos para produzir um efeito anti-proliferativo e um efeito inibitório de mtor quinase em uma animal de sangue quente, método para tratar doenças, e, composição farmacêutica |
| CN101998680B (zh) * | 2009-08-24 | 2016-01-13 | 中兴通讯股份有限公司 | 帧序列号的发送方法及节点b和服务无线网络控制器 |
| AU2011336973A1 (en) | 2010-12-03 | 2013-07-11 | Allergan, Inc. | Pharmaceutical compositions comprising 3,4- dihydroisoquinolin-2(1 H)-yl-3-phenylurea derivatives having formyl peptide receptor like-1 (FPRL-1) agonist or antagonist activity |
| AU2012214265A1 (en) | 2011-02-11 | 2013-09-05 | Allergan, Inc. | Novel 1-(1-oxo-1,2,3,4-tetrahydroisoquinolin-7-yl)urea derivatives as N-formyl peptide receptor like-1 (FPRL-1) receptor modulators |
| WO2013009543A1 (en) | 2011-07-11 | 2013-01-17 | Allergan, Inc. | Polycyclic pyrrolidine-2,5-dione derivatives as -formyl peptide receptor like-1 (fprl-1) receptor modulators |
| AU2012329098B2 (en) * | 2011-10-26 | 2017-08-03 | Allergan, Inc. | Amide derivatives of N-urea substituted amino acids as formyl peptide receptor like-1 (FPRL-1) receptor modulators |
| US8492556B2 (en) * | 2011-11-10 | 2013-07-23 | Allergan, Inc. | 2,5-Dioxoimidazolidin-1-yl-3-phenylurea derivatives as formyl peptide receptor like-1 (FPRL-1) receptor modulators |
| US8541577B2 (en) | 2011-11-10 | 2013-09-24 | Allergan, Inc. | Aryl urea derivatives as N-formyl peptide receptors like-1 (FPRL-1) receptor modulators |
| AU2013221749A1 (en) | 2012-02-16 | 2014-09-11 | Allergan, Inc. | Imidazolidine-2,4-dione derivatives as N-formyl peptide receptor 2 modulators |
| SG11201406629VA (en) | 2012-04-16 | 2014-11-27 | Allergan Inc | (2-ureidoacetamido)alkyl derivatives as formyl peptide receptor 2 modulators |
| CN110279684B (zh) | 2013-03-06 | 2023-02-28 | 阿勒根公司 | 用于治疗眼部炎性疾病的甲酰基肽受体2激动剂的用途 |
| JP6196328B2 (ja) | 2013-03-06 | 2017-09-13 | アラーガン、インコーポレイテッドＡｌｌｅｒｇａｎ，Ｉｎｃｏｒｐｏｒａｔｅｄ | 皮膚疾患を治療するためのホルミルペプチド受容体２アゴニストの使用 |
| US9428549B2 (en) | 2013-07-16 | 2016-08-30 | Allegran, Inc. | Derivatives of N-urea substituted amino acids as formyl peptide receptor modulators |
| JP6496728B2 (ja) | 2013-11-21 | 2019-04-03 | アラーガン、インコーポレイテッドＡｌｌｅｒｇａｎ，Ｉｎｃｏｒｐｏｒａｔｅｄ | ホルミルペプチド受容体の調節因子としてのカルバミン酸フェニル誘導体 |
| US9920013B2 (en) | 2014-01-29 | 2018-03-20 | Allergan, Inc. | 2,5-dioxoimidazolidin-1-yl-3-urea derivatives as formyl peptide modulators |
| WO2015116574A1 (en) | 2014-01-29 | 2015-08-06 | Allergan, Inc. | Urea hydantoin derivatives as formyl peptide modulators |
| US9663457B2 (en) | 2014-04-09 | 2017-05-30 | Allergan, Inc. | Carbamoyl hydrazine derivatives as formyl peptide modulators |
| ES2788700T3 (es) | 2014-05-21 | 2020-10-22 | Allergan Inc | Derivados de imidazol como moduladores del receptor de péptido formilado |
| JP7032323B6 (ja) | 2016-03-28 | 2023-12-18 | アラーガン、インコーポレイテッド | Ｎ－ホルミルペプチド受容体モジュレーターとしてのフェニル尿素誘導体 |
| AU2017249047B2 (en) | 2016-04-12 | 2021-08-05 | Allergan, Inc. | Phenyl urea derivatives as N-formyl peptide receptor modulators |
-
2015
- 2015-05-21 ES ES15726498T patent/ES2788700T3/es active Active
- 2015-05-21 CA CA2948876A patent/CA2948876A1/en not_active Abandoned
- 2015-05-21 US US15/312,367 patent/US10301269B2/en active Active
- 2015-05-21 AU AU2015264021A patent/AU2015264021B2/en not_active Ceased
- 2015-05-21 JP JP2016568605A patent/JP6660889B2/ja not_active Expired - Fee Related
- 2015-05-21 RU RU2016145596A patent/RU2748652C2/ru active
- 2015-05-21 KR KR1020167035670A patent/KR20170005121A/ko not_active Ceased
- 2015-05-21 CN CN201580026983.9A patent/CN106458921B/zh active Active
- 2015-05-21 BR BR112016027133A patent/BR112016027133A8/pt not_active Application Discontinuation
- 2015-05-21 WO PCT/US2015/032069 patent/WO2015179707A1/en not_active Ceased
- 2015-05-21 EP EP15726498.7A patent/EP3145916B1/en active Active
- 2015-05-21 DK DK15726498.7T patent/DK3145916T3/da active
-
2019
- 2019-05-22 US US16/419,317 patent/US10800744B2/en active Active
-
2020
- 2020-05-25 AU AU2020203420A patent/AU2020203420B2/en not_active Ceased